Loading…
Dhansa Labs (DHANSA)₹26.00−0.76%Pesticides & Agrochemicals
In the Jun 2026 quarter (consolidated), Dhansa Labs reported sales of ₹30.63 Cr and net profit of ₹0.74 Cr. For the year to Mar 2026, sales were ₹142 Cr and net profit ₹6.01 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 32.90 | 40.62 | 30.63 |
| Expenses | 30.16 | 37.98 | 27.82 |
| Operating Profit | 2.58 | 2.45 | 2.66 |
| OPM % | 7.8% | 6.0% | 8.7% |
| Other Income | 0.31 | 0.89 | 0.04 |
| Interest | 0.31 | 0.37 | 0.70 |
| Depreciation | 0.56 | 0.55 | 0.45 |
| Profit before tax | 1.99 | 2.39 | 1.52 |
| Tax % | 54.5% | 16.7% | 52.4% |
| Net Profit | 0.91 | 2.01 | 0.74 |
| EPS (Rs) | 0.35 | 0.79 | 0.26 |
| Mar 2026 | |
|---|---|
| Sales | 142 |
| Expenses | 131 |
| Operating Profit | 11.03 |
| OPM % | 8.0% |
| Other Income | 1.01 |
| Interest | 2.99 |
| Depreciation | 2.01 |
| Profit before tax | 6.99 |
| Tax % | 25.0% |
| Net Profit | 6.01 |
| EPS (Rs) | 2.20 |
| Dividend payout % | 0.0% |
| Mar 2026 | |
|---|---|
| Equity Capital | 25.01 |
| Reserves | 74.16 |
| Borrowings | 39.97 |
| Other Liabilities | 11.95 |
| Total Liabilities | 151 |
| Fixed Assets | 23.93 |
| CWIP | 23.04 |
| Investments | 0.00 |
| Other Assets | 104 |
| Inventories | 32.10 |
| Trade receivables | 54.07 |
| Cash & equivalents | 2.01 |
| Total Assets | 151 |
| Mar 2026 | |
|---|---|
| Cash from operating activity | −3.99 |
| Cash from investing activity | −47.92 |
| Cash from financing activity | 53.90 |
| Net cash flow | 0.99 |
| Capex | 49.35 |
| Free cash flow | −54.03 |
| CFO / OP % | −31.0% |
| Mar 2026 | |
|---|---|
| Debtor days | 138 |
| Inventory days | 90 |
| Days payable | 18 |
| Cash conversion cycle | 210 |
| Working capital days | 169 |
For the Jun 2026 quarter, Dhansa Labs reported sales of ₹30.63 Cr and net profit of ₹0.74 Cr. The operating margin was 8.7%.
Dhansa Labs' sales for the year to Mar 2026 were ₹142 Cr.
Net profit for the year to Mar 2026 was ₹6.01 Cr. Earnings per share over the same trailing period were ₹2.20.
Dhansa Labs reported borrowings of ₹39.97 Cr at Mar 2026, against cash and equivalents of ₹2.01 Cr.
Cash from operations was −₹3.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹54.03 Cr.